Taiwan’s advancing cell and gene therapy (CGT) ecosystem is creating strong partnership opportunities for U.S. companies.

Tanzania allocates budget to strengthen healthcare services

U.S. companies face ongoing delays in Guatemala’s sanitary registration process for medicines and related products, affecting both new applications and renewals

Demand is booming in Brazil for semaglutide generic drugs.  

The Drug Authority designed to help streamline applications and track the process of medical device registration via its online service portal. 

Opening doors for U.S. Medtech and Digital Health Innovation in Ireland’s evolving Healthcare System

A growing Vietnamese pharma sector provides significant opportunities for U.S. exporters.

Healthcare is one of five strategic sectors for AI adoption under Singapore’s National AI Strategy, offering U.S firms’ opportunities for export.

Japan’s digital therapeutics (DTx) market is expected to rapidly grow, presenting opportunities for U.S. DTx companies.

Malaysia’s $1B nutritional supplement market by 2030 offers growing opportunities for U.S. companies amid rising health awareness and aging trends.

To market a medical device in Egypt, manufacturers must register their products with the Egyptian Drug Authority (EDA). 

India’s commitment to improve patient lives through automation in surgery presents opportunities for U.S. companies.

For U.S. companies, this market dynamic presents a timely and strategic opportunity to provide solutions across a wide spectrum of healthcare needs

The German telehealth market is growing due to aging population and an growing need for medical services, alongside a push for digitalization from Government.

South Korea’s $4.7B health supplement market ($20B by 2030) offers strong potential for U.S. firms, but regulatory compliance is critical.